Insight Molecular Diagnostics IMDX
NASDAQ IMDX
$3.44 -0.03 (-0.86%)
At close: Oct 2, 2026 · 4:00 PM EDT

Insight Molecular Diagnostics (IMDX) Income from Discontinued Operations (2022 - 2023)

Updated

Insight Molecular Diagnostics (IMDX) recorded Income from Discontinued Operations of -$2.93 million in FY2023, compared with -$54.29 million in FY2022.

Analysis

Insight Molecular Diagnostics (IMDX) Income from Discontinued Operations (2022 - 2023) Analysis & Trends

  • Per Business Quant data, IMDX's Income from Discontinued Operations was -$54.29 million in FY2022 and -$20.49 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn -
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn -
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn -
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn -
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn -
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn -
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn -
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn -
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn -74.00 Mn
10 Insight Molecular Diagnostics 112.22 Mn 35.94 Mn 157,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 -2.93 Mn
Dec 31, 2022 -32.96 Mn
Sep 30, 2022 -7.52 Mn
Jun 30, 2022 -6.94 Mn
Mar 31, 2022 -6.88 Mn
API Access

Insight Molecular Diagnostics Income from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=IMDX&period=max&api_key=YOUR_API_KEY